Concepedia

Neil Formica

NF

15

Publications

2K

Citations

15

H-Index

2000

Active since

Affiliations

Novavax (United States)(Current)

University of Maryland, Baltimore

CSL (Australia)

Australian National University

The University of Melbourne

Neil Formica is an author at Novavax (United States) specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

2000–2022

15

Publications

15

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

Neil Formica, Raburn M. Mallory, Gary Albert et al. · PLoS Medicine · 2021 · 112 citations · Full text

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Terry Nolan, Peter Richmond, Neil Formica et al. · Vaccine · 2008 · 89 citations

, , +8

Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia

Anthony T. Newall, Julia Brotherton, Helen Quinn et al. · Clinical Infectious Diseases · 2008 · 86 citations · Full text

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

Terry Nolan, Peter Richmond, Maryanne Skeljo et al. · Vaccine · 2008 · 78 citations

, , +8

Rows per page

1–5 of 15